Ideal Power Raises $30 Million to Accelerate B-TRAN Commercialisation and Data Centre Expansion

19 May 2026 | NEWS

Funding will support customer design wins, production ramp-up and strategic growth initiatives as demand rises for efficient power semiconductor technologies in AI and hyperscale data centres.

Ideal Power Inc. (Nasdaq: IPWR) ("Ideal Power," the "Company," "we," or "our"), pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, announced that it has entered into a definitive agreements with certain institutional investors for the purchase and sale of an aggregate of 5,291,005 shares of common stock (or common stock equivalents) priced at the market under Nasdaq rules. The offering is expected to result in gross proceeds of approximately $30 million, before deducting offering expenses.

The Company intends to use the net proceeds from these financings to advance commercialisation of B-TRAN®, including customer design-ins, custom development programs, initial production ramp with strategic partners, and general corporate and working capital purposes.

"This financing strengthens our balance sheet at a pivotal moment for Ideal Power," said David Somo, President and Chief Executive Officer of Ideal Power. "With the accelerating demand for data centres and power, hyperscalers have focused on more efficient power architectures. This financing allows us to be well-positioned to ramp the commercialisation of our B-TRAN® technology, advance customer engagements, and capitalise on the significant opportunities emerging across industrial markets."

Titan Partners, a division of American Capital Partners, is acting as the sole placement agent for the financing.

The offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-292492) (including a base prospectus) previously filed with the U.S. Securities and Exchange Commission (the "SEC") on December 30, 2025, and declared effective on January 9, 2026. The common stock (or common stock equivalents) is being offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective Registration Statement.